1)Sadamoto Y, Kubo H, Harada N, et al:Preoperative diagnosis and staging of gallbladder carcinoma by EUS. Gastrointest Endosc 58:536-541, 2003
2)Hirai I, Kimura W, Fuse A, et a l:Evaluation of preoperative portal embolization for safe hepatectomy, with special reference to assessment of nonembolized lobe function with 99mTc-GSA SPECT scintigraphy. Surgery 133:495-506, 2003
3)幕内雅敏,高山忠利,山崎 晋,他:肝硬変合併肝癌治療のStrategy.外科診療29:1530-1536,1987
4)Yeh CN, Jan YY, Chen MF:Management of unsuspected gallbladder carcinoma discovered during or following laparoscopic cholecystectomy. Am Surg 70:256-258, 2004
5)Sano T, Ajiki T, Hirata K, et al:A recurrent case of an early gallbladder carcinoma after laparoscopic cholecystectomy. Hepatogastroenterology 51:672-674, 2004
6)吉川達也:胆嚢癌外科治療の現況.第34回日本胆道外科研究会アンケート調査報告,2005
7)Suzuki S, Yokoi Y, Kurachi K, et al:Appraisal of surgical treatment for pT2gallbladder carcinomas. World J 28:160-165, 2004
8)又木雄弘,高尾尊身,新地洋之,他:臨床病理学的因子に基づいたss胆嚢癌に対する肝切除術式の検討.日消外学誌37:274-282,2004
9)Endo I, Shimada H, Takimoto A, et al:Microscopic liver metastasis:prognostic factor for patients with pT2gallbladder carcinoma. World J Surg 28:692-696, 2004
10)Shimada H, Endo I, Sugita M, et al:Hepatic resection combined with portal vein or hepatic artery reconstruction for advanced carcinoma of the hilar bile duct and gallbladder. World J Surg 27:1137-42, 2003